FOXD1 and hepatocellular carcinoma: To investigate the PI3K/AKT pathway activation in facilitating the stimulation of EMT by FOXD1‐AS1, HCC cells with suppressed expression of FOXD1‐AS1 were noted after treatment with 20 uM of PI3K/AKT pathway activator 740Y‐P.